Fact CheckerSign in

NCT05116137Enrolling by invitation

The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors

The Impact of Resistance ExerciSe on Muscle Mass in GlioblaSToma Survivors (RESIST)

Source: ClinicalTrials.gov · Last updated 29 May 2026

Brief summary (registry, in English)

Glioblastoma patients are confronted with a debilitating disease associated with a low survival rate and poor quality of life. The goal of this study will be to reach a largely underrepresented population in the exercise literature and explore the role of a tailored circuit-based resistance training program on functional fitness (i.e., ability to carry out tasks of daily living) and associated health outcomes (e.g., quality of life) for GBM patients on active treatment.

Status (registry)
Enrolling by invitation
Study type
Interventional
Enrollment
24 (estimated)
First submitted
19 Oct 2021
Start date
1 Mar 2022
Primary completion date
31 Dec 2027
Lead sponsor
Nova Scotia Health Authority
Diseases
Glioblastoma
NCT number
NCT05116137

What you commit to

  • Study type: Interventional
  • Planned participants: 24
  • From 1 Mar 2022 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • unstable or symptomatic cardiac or pulmonary disease, injury or co-morbid disease that precludes ability to safely exercise
  • uncontrolled seizures associated with impaired awareness

Other

  • significant cognitive limitations

Who the study is looking for

  • histologically confirmed diagnosis of either primary or secondary GBM
  • received any dose of DEX
  • Karnofsky Performance Status (KPS) \>70
  • English fluency
  • physician approval
  • willingness to travel to Halifax to participate.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
QEII Health Sciences Centre
Coordinator of this site? Confirm its status
HalifaxCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.